OralInsulin MCP
Early signalEvidence-backed oral insulin intelligence for agents
Launched 1mo ago
Signal
22
Velocity
27
What this means
23Founder Conviction Index: 23 — low signal.
Few of the conviction sub-signals (reputation, velocity, buyer-intent, tagline clarity) are firing yet.
Prediction
Top-5 finish probability
19%
today
Projected end-of-day votes
3range 2–4
Trajectory
stable
Not enough snapshots yet to detect trajectory.
About
OralInsulin MCP gives AI agents and human decision-makers a structured, source-backed view of the oral and oromucosal insulin landscape. It tracks clinical programs, market estimates, regulatory developments, manufacturers, partnerships and qualified relationship signals through MCP tools and a human-facing site. Built to help researchers, companies, investors and healthcare organizations evaluate evidence, compare claims and connect. Ask it anything: GPT-6 Astra answers by querying the same MCP
AI Summary
OralInsulin MCP provides a comprehensive, evidence-based overview of the oral and oromucosal insulin landscape, including clinical programs, market estimates, and regulatory developments. It utilizes AI to assist researchers, companies, investors, and healthcare organizations in evaluating evidence and making informed decisions.
Attention & discussion velocity
Performance
Velocity27
Vote pace vs average
Momentum27
Sustained over 6h
Virality41
Spread × engagement
Engagement—
not measured
Signal sources
2 of 6 active- Launch tracking2 readings since we picked it up
- AI analysisAI Agents
- Comment intelligencethread not yet analysed
- Outside discussionnot checked — domain is a storefront or shared
- Revenue signalsno match on this domain
- Editorial scoringbelow the signal threshold for this pass
A source that found nothing is a measurement. A source that has not run is a gap. Neither means the launch lacks the thing.
